Ma Yinglong's "erythromycin ointment" and sunflower pharmaceutical's "Yinqiao cold capsule" are unqualified!
-
Last Update: 2020-01-19
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the "notice on drug quality and safety in Beijing in the second half of 2019" issued by the State Food and drug administration, the "erythromycin ointment" (batch number 190126) produced by Ma Yinglong Pharmaceutical Group Co., Ltd was found to be unqualified in the "content determination" item by Beijing Institute of drug inspection, and the source of the tested product was Beijing xuannei Pharmaceutical Co., Ltd The total number of molds and yeasts in the batch number of "Yinqiao cold wind capsule" (batch number 20181002) produced by Heilongjiang sunflower Pharmaceutical Co., Ltd is unqualified, and the source of the sample is Beijing Jingmeng Huikang Pharmaceutical Co., Ltd.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
